Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Clinical trial NCT07745361 · RECRUITING

Trial details

NCT number: NCT07745361
Sponsor: Monte Rosa Therapeutics, Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate Cancer Prostate Cancer Prostate Cancer (Adenocarcinoma)

Start date: 2026-08-01
Primary completion: 2027-10-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.